Covid-19 drug enters human testing phase.

LAHORE -- The de Khon Global and its partners in The Netherlands and Turkey have reportedly reached the human testing phase in the development of a drug to treat Covid-19.

According to a press release, the breakthrough has come from the VSY Biotechnology B.V., based in Netherlands, one of the strategic partner company of de Khon Global. The drug, named TR-C 19, can neutralise the virus under laboratory conditions and it is now at authority approval stage for usage on voluntary Covid-19 patients and clinical trials.

Dr Faisal Q Khokhar, the executive director of Remington Pharmaceuticals, stated: 'We are committed to making the impossible possible. We are facing this public health challenge head on by collaborating with our industry partners in Europe and...